Company Filing History:
Years Active: 2005
Title: Innovations of Anthony M Stephan
Introduction
Anthony M Stephan is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for encapsidating recombinant vectors in AAV particles. His work has implications for gene therapy and other medical applications.
Latest Patents
Anthony M Stephan holds a patent titled "Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles." This invention provides isolated recombinant polynucleotides that comprise elements promoting encapsidation into AAV particles. The patent details the use of a non-AAV ITR encapsidation element, such as the P1 sequence located within the AAV S1 integration site of human chromosome 19, operably linked to one or more heterologous genes. The constructs can be integrated into a mammalian cell genome, maintained episomally, or provided transiently. He has 1 patent to his name.
Career Highlights
Anthony M Stephan has worked with Targeted Genetics Corporation, where he has been involved in pioneering research and development in gene therapy technologies. His expertise in encapsidation methods has positioned him as a key figure in advancing therapeutic applications.
Collaborations
Some of his notable coworkers include Dara H Lockert and Carmel M Lynch, who have collaborated with him on various projects within the biotechnology sector.
Conclusion
Anthony M Stephan's innovative work in the field of biotechnology, particularly in the encapsidation of recombinant vectors, showcases his contributions to advancing medical science. His patent and collaborations reflect his commitment to improving gene therapy techniques.